Probabilistic risk assessment of residential exposure to electric arc furnace steel slag using Bayesian model of relative bioavailability and PBPK modeling of manganeseRISK ANALYSISIF3.32024-04-152OA
Use of physiologically based pharmacokinetic modeling to support development of an acute (24-hour) health-based inhalation guideline for manganeseREGULATORY TOXICOLOGY AND PHARMACOLOGYIF3.52023-12-012OAAI
A multi-tiered hierarchical Bayesian approach to derive toxic equivalency factors for dioxin-like compoundsREGULATORY TOXICOLOGY AND PHARMACOLOGYIF3.52023-09-013PRE
Manganese relative oral bioavailability in electric arc furnace steel slag is influenced by high iron content and low bioaccessibilityTOXICOLOGICAL SCIENCESIF4.12023-04-192OAAI
Cardiotoxicity Hazard and Risk Characterization of ToxCast Chemicals Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes from Multiple DonorsCHEMICAL RESEARCH IN TOXICOLOGYIF3.82021-08-2730OAAI
Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes as an in vitro model in toxicology: strengths and weaknesses for hazard identification and risk characterizationEXPERT OPINION ON DRUG METABOLISM & TOXICOLOGYIF3.42021-03-0836OAAI
Relationships between constituents of energy drinks and beating parameters in human induced pluripotent stem cell (iPSC)-Derived cardiomyocytesFOOD AND CHEMICAL TOXICOLOGYIF3.52021-03-018OAAI
A Bayesian Method for Population-wide Cardiotoxicity Hazard and Risk Characterization Using an In Vitro Human ModelTOXICOLOGICAL SCIENCESIF4.12020-10-2027OAAI
Population-based toxicity screening in human induced pluripotent stem cell-derived cardiomyocytesTOXICOLOGY AND APPLIED PHARMACOLOGYIF3.42019-10-0157OAAI
Thorough QT/QTc in a Dish: An In Vitro Human Model That Accurately Predicts Clinical Concentration-QTc RelationshipsCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52018-12-0233OAAI